polymyxin B derivatives (Cantab Anti-Infectives)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepolymyxin B derivatives (Cantab Anti-Infectives)
Drug Alias NameCA-1061CA-1087CA-782CA-824CA-900 +[13] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCantab Anti-Infectives Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCantab Anti-Infectives LtdSpero Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A